Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT01245959 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

476

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Docetaxel, cisplatin and fluorouracil
RADIATION: Concurrent chemoradiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]